MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
Department of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.
Int J Epidemiol. 2023 Feb 8;52(1):107-118. doi: 10.1093/ije/dyac131.
Cluster-randomized trials (CRTs) involve randomizing groups of individuals (e.g. hospitals, schools or villages) to different interventions. Various approaches exist for analysing CRTs but there has been little discussion around the treatment effects (estimands) targeted by each.
We describe the different estimands that can be addressed through CRTs and demonstrate how choices between different analytic approaches can impact the interpretation of results by fundamentally changing the question being asked, or, equivalently, the target estimand.
CRTs can address either the participant-average treatment effect (the average treatment effect across participants) or the cluster-average treatment effect (the average treatment effect across clusters). These two estimands can differ when participant outcomes or the treatment effect depends on the cluster size (referred to as 'informative cluster size'), which can occur for reasons such as differences in staffing levels or types of participants between small and large clusters. Furthermore, common estimators, such as mixed-effects models or generalized estimating equations with an exchangeable working correlation structure, can produce biased estimates for both the participant-average and cluster-average treatment effects when cluster size is informative. We describe alternative estimators (independence estimating equations and cluster-level analyses) that are unbiased for CRTs even when informative cluster size is present.
We conclude that careful specification of the estimand at the outset can ensure that the study question being addressed is clear and relevant, and, in turn, that the selected estimator provides an unbiased estimate of the desired quantity.
整群随机试验(cluster-randomized trials,CRTs)涉及将个体(如医院、学校或村庄)随机分为不同的干预组。目前存在多种分析 CRTs 的方法,但针对每种方法所针对的治疗效果(估计量),讨论甚少。
我们描述了 CRTs 可以解决的不同估计量,并展示了通过不同分析方法的选择如何通过从根本上改变所提出的问题或等效的目标估计量来影响结果的解释。
CRTs 可以解决个体平均治疗效果(参与者之间的平均治疗效果)或聚类平均治疗效果(聚类之间的平均治疗效果)。当参与者的结果或治疗效果取决于聚类大小(称为“信息性聚类大小”)时,这两个估计量可能会有所不同,这种情况可能由于小聚类和大聚类之间的人员配备水平或参与者类型的差异等原因而发生。此外,常见的估计器,如混合效应模型或具有可交换工作相关结构的广义估计方程,在聚类大小时存在信息时,可能会对个体平均和聚类平均治疗效果产生有偏估计。我们描述了替代估计器(独立性估计方程和聚类水平分析),即使在存在信息性聚类大小时,它们对于 CRTs 也是无偏的。
我们得出结论,在开始时仔细指定估计量可以确保所解决的研究问题清晰且相关,并且所选的估计器可以为所需数量提供无偏估计。